2023-05-30 03:26 |
9 p, 1.4 MB |
Preliminary evaluation of the safety and efficacy of glucose solution infusion through the hepatic artery on irreversible electroporation focusing
/
Sarreshtehdari, Amirhossein (Universitat Pompeu Fabra. Departament de Ciències Experimentals i de la Salut) ;
Burdío, Fernando (Institut Hospital del Mar d'Investigacions Mèdiques) ;
López-Alonso, Borja (Universidad de Zaragoza. Department of Electronic Engineering and Communications) ;
Lucía, Óscar (Universidad de Zaragoza. Department of Electronic Engineering and Communications) ;
Burdio, José Miguel (Universidad de Zaragoza. Department of Electronic Engineering and Communications) ;
Villamonte, María (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Andaluz Martínez, Anna (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
García Arnas, Félix (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Berjano, Enrique (Universitat Politècnica de València. Departament d'Enginyeria Electrònica) ;
Moll Sánchez, Xavier (Universitat Autònoma de Barcelona. Fundació Hospital Clínic Veterinari)
Due to electrical features of the tissue, such as impedance, which have a significant impact on irreversible electroporation (IRE) function, the administration of glucose solution 5% (GS5%) through the hepatic artery would focus IRE on scattered liver tumors. [...]
2023 - 10.1038/s41598-023-33487-3
Scientific reports, Vol. 13 (may 2023)
|
|
2023-05-09 13:14 |
|
2023-05-09 12:44 |
|
2023-05-09 12:26 |
|
2023-05-05 11:44 |
21 p, 1.3 MB |
Canine Leishmaniosis : tools for diagnosis in veterinary practice in Colombia
/
Acero, Víctor ;
Ángel, Perla ;
Fonseca, Esther ;
Ferrer i Caubet, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Roura, Xavier (Universitat Autònoma de Barcelona. Hospital Clínic Veterinari)
The objective of this article is to perform a critical analysis and guide veterinarians in the management a of canine Leishmaniosis. A systematic literature review was performed between 2005 and 2014 including scientific papers which take into account experiences and reports of: pathogenesis, diagnosis, clinical presentation, treatment, vaccination, prevention and control strategies. [...] Se realiza un análisis crítico con el fin de orientar a los médicos veterinarios en el tema de Leishmaniosis canina. Se realizó una revisión de literatura a partir del año 2005 de manera sistemática considerando artículos científicos donde se tuvieran en cuenta experiencias y reportes de la patogenia, diagnóstico, presentación clínica de la enfermedad, tratamiento, la vacunación, el abordaje de los casos, estrategias de prevención y control y las consideraciones que se deben tener, según el país, ante la sospecha o confirmación a de un paciente positivo, entre estos aspectos, la eutanasia. [...]
2015
Revista MZV Córdoba, Vol. 20 Núm. 3 (2015) , p. 4822-4842
|
|
2023-05-05 11:25 |
21 p, 1.2 MB |
PAR2 Pepducin-Based Suppression of Inflammation and Itch in Atopic Dermatitis Models
/
Barr, T.P. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Garzia, C. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Guha, S. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Fletcher, E.K. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Nguyen, N. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Wieschhaus, A.J. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Ferrer i Caubet, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Covic, L. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research) ;
Kuliopulos, A. (Tufts University School of Medicine. Center of Hemostasis and Thrombosis Research)
PAR2 has been proposed to contribute to lesion formation and intense itch in atopic dermatitis. Here, we tested the ability of a cell-penetrating pepducin, PZ-235, to mitigate the potentially deleterious effects of PAR2 in models of atopic dermatitis. [...]
2019 - 10.1016/j.jid.2018.08.019
The Journal of investigative dermatology, Vol. 139 Núm. 2 (february 2019) , p. 412-421
|
|
2023-05-05 11:25 |
|
2023-05-05 11:25 |
|
2023-05-05 11:25 |
|
2023-05-05 11:25 |
7 p, 505.6 KB |
Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis
/
Segarra, S. (R&D Animal Health Bioiberica) ;
Miró, G. (Universidad Complutense de Madrid. Departamento de Sanidad Animal) ;
Montoya, A. (Universidad Complutense de Madrid. Departamento de Sanidad Animal) ;
Pardo-Marín, Luis (Universidad de Murcia. Laboratorio Interdisciplinario de Análisis Clínicos Interlab) ;
Boqué, Noemí (Centre Tecnològic de Nutrició i Salut) ;
Ferrer i Caubet, Lluís (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Cerón, José Joaquín (Universidad de Murcia. Laboratorio Interdisciplinario de Análisis Clínicos Interlab)
First-line treatment for canine leishmaniosis (CanL) is N-methylglucamine antimoniate (MGA) combined with allopurinol. However, in some dogs allopurinol may induce hyperxanthinuria leading to urolithiasis. [...]
2017 - 10.1016/j.vetpar.2017.04.014
Veterinary Parasitology, Vol. 239 (30 2017) , p. 50-56
|
|
|
|